Pediatric Recurrent Epistaxis: Diagnostic Approach and Management
Initial Evaluation and Common Causes
- The American Academy of Otolaryngology-Head and Neck Surgery recommends beginning with anterior rhinoscopy to identify local causes, then performing nasal endoscopy for recurrent unilateral bleeding or bleeding despite prior treatment, and obtaining coagulation studies with hematology referral when there is a positive family history of bleeding or severe/bilateral recurrent episodes 1, 2
- Digital trauma and nasal mucosal irritation are the most frequent causes in otherwise healthy children, typically affecting the anterior nasal septum 3, 4
- Nasal foreign bodies present with unilateral epistaxis, rhinorrhea, and foul smell in 7% of cases; bleeding occurs in 30% of foreign body cases either from the object itself or during removal 1, 2, 5
- Nasal septal deviation can contribute to recurrent bleeding through altered airflow and mucosal trauma 1, 6
Uncommon but Critical Causes
- Juvenile nasopharyngeal angiofibroma occurs in adolescent males, presenting with unilateral, unprovoked, profuse epistaxis in 60-76% of cases; examination of the posterior nasal cavity and nasopharynx is mandatory in adolescent males with these symptoms 1, 2, 3, 4
- Nasal malignancies present with unilateral nasal obstruction and epistaxis; these may not be visible on anterior rhinoscopy and delayed diagnosis can cause life-threatening bleeding 1, 2, 7
- Disk battery foreign bodies can cause tissue necrosis and septal perforation in as little as 3 hours 1, 2, 5, 7
Diagnostic Testing Algorithm
- Perform anterior rhinoscopy on all patients after removing any blood clot to identify the bleeding source 5, 7
- Use an otoscope in young children for visualization 5, 7
- Look for septal deviation, perforation, telangiectasias, masses, and foreign bodies 1, 6
- Nasal endoscopy localizes the bleeding site in 87-93% of cases and can identify posterior sources not visible on anterior rhinoscopy 1, 2
Hereditary Hemorrhagic Telangiectasia (HHT)
- Assess for nasal and oral mucosal telangiectasias in children with recurrent bilateral nosebleeds or positive family history 8
- HHT occurs in 1 in 5,000-18,000 individuals and is often underdiagnosed or diagnosed late 8
- Nosebleeds are the main symptom in >90% of HHT patients 8
Epistaxis in Children: Differential Diagnosis and Management
Etiology and Risk Factors
- The American Academy of Pediatrics recommends considering coagulopathy or bleeding disorder in children with severe or bilateral recurrent episodes of epistaxis, associated bruising, petechiae, or other bleeding manifestations 9, 10
- Immune thrombocytopenia (ITP) can present with mucosal bleeding, including epistaxis, in young children 9, 10
- Adenoidal hypertrophy is a common acquired anatomic cause of nasal obstruction in infants and children, leading to mouth breathing and potential mucosal trauma 11
- Laryngopharyngeal reflux can cause nasal congestion and inflammation in infants, particularly those with prematurity, neuromuscular disease, or cleft palate 11
Diagnostic Approach
- The American Academy of Pediatrics suggests obtaining coagulation studies with hematology referral when there is a positive family history of bleeding disorders, severe or bilateral recurrent episodes, or associated bruising or petechiae suggesting ITP 9, 10
- The American Academy of Pediatrics recommends against obtaining imaging (CT or plain films) to distinguish acute bacterial sinusitis from viral URI, as they do not contribute to diagnosis 12
- Imaging is not necessary for uncomplicated epistaxis in children 12
Laboratory Evaluation for Frequent Nosebleeds in Toddlers
Indications for Laboratory Testing
- The American Academy of Pediatrics recommends laboratory evaluation in toddlers with a history of significant bleeding after medical procedures, which increases suspicion for bleeding disorders 13
- A positive family history of bleeding disorders, such as hemophilia or von Willebrand disease, necessitates testing in toddlers with frequent nosebleeds 13
- Toddlers with associated bleeding manifestations, such as bruising or petechiae, may require workup for coagulopathy, and the American Academy of Pediatrics recommends laboratory evaluation in these cases 13
Laboratory Panel
- A complete blood count (CBC) with differential is recommended to evaluate platelet count and identify thrombocytopenia, anemia from blood loss, or other hematologic abnormalities in toddlers with frequent nosebleeds 13
- Coagulation studies, including PT/PTT, are recommended to screen for coagulation factor deficiencies in toddlers with suspected bleeding disorders 13
Diagnostic Considerations
- The American Academy of Pediatrics recommends documenting medications in toddlers with frequent nosebleeds, as certain drugs can affect coagulation test results and increase bleeding risk 13
- Assessment for systemic conditions, including Ehlers-Danlos syndrome or other connective tissue disorders, is recommended through history and examination in toddlers with frequent nosebleeds 13
Management of Pediatric Anterior Epistaxis
Epidemiology and Etiology
- The American Academy of Otolaryngology‑Head and Neck Surgery reports that most epistaxis in 7‑year‑old children arises from the anterior nasal septum (Kiesselbach’s area), primarily due to digital trauma and nasal mucosal irritation. Evidence level not specified. 14
Acute Hemostasis
- The American Academy of Otolaryngology‑Head and Neck Surgery recommends applying firm, continuous pressure to the soft lower third of the nose for 10–15 minutes, with the child sitting upright and the head tilted slightly forward, as the first‑line treatment to achieve bleeding control. Evidence level not specified. 14
Vascular Abnormalities as a Cause of Epistaxis
General Role of Nasal Vascular Abnormalities
- The American Academy of Otolaryngology‑Head and Neck Surgery (AAO‑HNS) identifies abnormal nasal vasculature—including hereditary hemorrhagic telangiectasia (HHT)‑related lesions, thin‑walled arterioles and capillaries with surrounding inflammation, and dilated mucosal vessels—as a well‑recognized cause of recurrent nosebleeds. 15
Hereditary Hemorrhagic Telangiectasia (HHT)
- The AAO‑HNS specifically recognizes abnormal nasal vasculature in HHT syndrome as a known etiology of recurrent epistaxis. 15
Anatomical Source of Most Nosebleeds
- The majority of epistaxis originates from the nasal septum, which receives a rich blood supply from the Kiesselbach plexus. 15
Management of Pediatric Anterior Epistaxis
Initial Compression Technique
- Apply firm, sustained compression of the soft lower third of the nose for 10–15 minutes without intermittent checking – this maneuver stops bleeding in the majority of children with active epistaxis. American Academy of Otolaryngology‑Head and Neck Surgery 16, 17 (Evidence level not specified).
Post‑Control Assessment
Anterior Rhinoscopy
- Perform anterior rhinoscopy on every child after clot removal to locate the bleeding source. American Academy of Otolaryngology‑Head and Neck Surgery 17 (Evidence level not specified).
History Taking & Severity Evaluation
- Review medication use, including aspirin and other anticoagulants, even though they are uncommon in children, because they can worsen nosebleeds. American Academy of Otolaryngology‑Head and Neck Surgery 17 (Evidence level not specified).
- Ask about personal or family history of bleeding disorders (e.g., hemophilia, von Willebrand disease). American Academy of Otolaryngology‑Head and Neck Surgery 17 (Evidence level not specified).
- Classify epistaxis as severe when bleeding lasts >30 minutes, is bilateral, or when the child has had >3 recent episodes; such cases require prompt evaluation. American Academy of Otolaryngology‑Head and Neck Surgery 17 (Evidence level not specified).
Chemical Cauterization Procedure
- When the bleeding site is visualized, perform chemical cauterization with silver nitrate after applying local anesthesia, limiting the application to the identified area only. American Academy of Otolaryngology‑Head and Neck Surgery 17 (Evidence level not specified).
Red‑Flag Indicators for Immediate Referral
- Active bleeding accompanied by hemodynamic instability or airway compromise. American Academy of Otolaryngology‑Head and Neck Surgery 17 (Evidence level not specified).
- Bleeding persisting >30 minutes over a 24‑hour period. American Academy of Otolaryngology‑Head and Neck Surgery 17 (Evidence level not specified).
- Bleeding from both nostrils or from the mouth. American Academy of Otolaryngology‑Head and Neck Surgery 17 (Evidence level not specified).
- Signs of acute hypovolemia such as tachycardia, syncope, or orthostatic hypotension. American Academy of Otolaryngology‑Head and Neck Surgery 17 (Evidence level not specified).